title: Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate.
abstract: The second messenger hydrogen peroxide is required for optimal activation of numerous signal transduction pathways, particularly those mediated by protein tyrosine kinases. One mechanism by which hydrogen peroxide regulates cellular processes is the transient inhibition of protein tyrosine phosphatases through the reversible oxidization of their catalytic cysteine, which suppresses protein dephosphorylation. Here we describe a structural analysis of the redox-dependent regulation of protein tyrosine phosphatase 1B (PTP1B), which is reversibly inhibited by oxidation after cells are stimulated with insulin and epidermal growth factor. The sulphenic acid intermediate produced in response to PTP1B oxidation is rapidly converted into a previously unknown sulphenyl-amide species, in which the sulphur atom of the catalytic cysteine is covalently linked to the main chain nitrogen of an adjacent residue. Oxidation of PTP1B to the sulphenyl-amide form is accompanied by large conformational changes in the catalytic site that inhibit substrate binding. We propose that this unusual protein modification both protects the active-site cysteine residue of PTP1B from irreversible oxidation to sulphonic acid and permits redox regulation of the enzyme by promoting its reversible reduction by thiols.
authors.affiliation: Section of Structural Biology, Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London SW3 6JB, UK.
authors.forename: Annette
authors.initials: A
authors.lastname: Salmeen
authors.forename: Jannik N
authors.initials: JN
authors.lastname: Andersen
authors.forename: Michael P
authors.initials: MP
authors.lastname: Myers
authors.forename: Tzu-Ching
authors.initials: TC
authors.lastname: Meng
authors.forename: John A
authors.initials: JA
authors.lastname: Hinks
authors.forename: Nicholas K
authors.initials: NK
authors.lastname: Tonks
authors.forename: David
authors.initials: D
authors.lastname: Barford
mesh_terms: D000577:Amides / Q000737:chemistry / Q000378:metabolism*; D019943:Amino Acid Substitution; D001665:Binding Sites; D003545:Cysteine / Q000378:metabolism; D004815:Epidermal Growth Factor / Q000494:pharmacology; D007328:Insulin / Q000494:pharmacology; D008958:Models, Molecular; D010084:Oxidation-Reduction / Q000187:drug effects; D010766:Phosphorylation; D011485:Protein Binding; D011487:Protein Conformation; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D011972:Receptor, Insulin / Q000737:chemistry / Q000378:metabolism; D012694:Serine / Q000378:metabolism; D013434:Sulfenic Acids / Q000737:chemistry / Q000378:metabolism*
chemical_list: D000577:Amides; D007328:Insulin; D013434:Sulfenic Acids; D012694:Serine; D004815:Epidermal Growth Factor; D011972:Receptor, Insulin; D054562:Protein Tyrosine Phosphatase, Non-Receptor Type 1; D017027:Protein Tyrosine Phosphatases; D003545:Cysteine